PATH has invested in 3 companies and its latest investment was Audere on Apr 17, 2023
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Audere is a Washington-based non-profit digital health company that develops devices including disease surveillance and testing accessibility for healthcare workers.
$9.3M
Apr 17, 2023
-
Batavia is a Netherlands-based biotechnology firm that offers services such as upstream process development, cell isolation, and cultivation for the healthcare sector.
$2.2M
Jul 07, 2019
-
Novavax is a Maryland-based biotechnology company that researches, develops and commercializes vaccines for the treatment of infectious diseases.
$2M
Jun 30, 2012
-
Frequently Asked Questions about PATH
What is PATH investing in?
PATH has invested in 3 companies including Audere, Batavia Biosciences and Novavax
What company did PATH invest in?
PATH invested in a total 3 companies including Audere, Batavia Biosciences and Novavax
What are the top 3 investments by PATH?
The top companies in which PATH invested are Audere, Batavia Biosciences and Novavax
